Cited by 1,970Atrial Fibrillation Management and OutcomesHeart Failure Treatment and ManagementCardiac Health and Mental Health

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study

Wang, Thomas J., Larson, Martin G., Levy, Daniel, Vasan, Ramachandran S., Leip, Eric P., Wolf, Philip A., D’Agostino, Ralph B., Murabito, Joanne M., Kannel, William B., Benjamin, Emelia J.·2003·Circulation

DOI 10.1161/01.cir.0000072767.89944.6e

Open this paper in CoChat — free account

Abstract

Background— Atrial fibrillation (AF) and congestive heart failure (CHF) frequently occur together, but there is limited information regarding their temporal relations and the combined influence of these conditions on mortality. Methods and Results— We studied participants in the Framingham Study with new-onset AF or CHF. Multivariable Cox proportional hazards models with time-dependent variables were used to evaluate whether mortality after AF or CHF was affected by the occurrence and timing of the other condition. Hazard ratios (HRs) were adjusted for time period and cardiovascular risk factors. During the study period, 1470 participants developed AF, CHF, or both. Among 382 individuals with both conditions, 38% had AF first, 41% had CHF first, and 21% had both diagnosed on the same day. The incidence of CHF among AF subjects was 33 per 1000 person-years, and the incidence of AF among CHF subjects was 54 per 1000 person-years. In AF subjects, the subsequent development of CHF was associated with increased mortality (men: HR 2.7; 95% CI, 1.9 to 3.7; women: HR 3.1; 95% CI, 2.2 to 4.2). Similarly, in CHF subjects, later development of AF was associated with increased mortality (men: HR 1.6; 95% CI, 1.2 to 2.1; women: HR 2.7, 95% CI, 2.0 to 3.6). Preexisting CHF adversely affected survival in individuals with AF, but preexisting AF was not associated with adverse survival in those with CHF. Conclusions— Individuals with AF or CHF who subsequently develop the other condition have a poor prognosis. Additional studies addressing the pathogenesis, prevention, and optimal management of the joint occurrence of AF and CHF appear warranted.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000072767.89944.6e

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Self-citation
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Self-citation
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Self-citation
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Self-citation
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426
Promotion of Atrial Fibrillation by Heart Failure in Dogs
Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,343
Congestive Heart Failure in the Community
Senni, M., Tribouilloy, C. M., Rodeheffer, R. J., Jacobsen, S. J., Evans, J. M., Bailey, K. R., & Redfield, M. M. (1998) · Circulation · doi:10.1161/01.cir.98.21.2282 · Cited by 1,088
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012

Show all 28 references

Research works printed but not linked: 6

10.1161/circ.84.1.2060110 · DOI
1993, Circulation, 87, VI102
1980, Arch Mal Coeur Vaiss, 73, 227
10.1161/circ.98.21.2282 · DOI
10.1161/circ.98.23.2574 · DOI
10.1161/circ.98.10.946 · DOI

Sorted by citations

Items 101–200 of 1,000

2020 Clinical guidelines for Atrial fibrillation and atrial flutter
Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 258
A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation
McManus, D. D., Lee, J., Maitas, O., Esa, N., Pidikiti, R., Carlucci, A., Harrington, J., Mick, E., & Chon, K. H. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2012.12.001 · Cited by 253
Atrial Fibrillation and the Risk of Sudden Cardiac Death
Chen, L. Y., Sotoodehnia, N., Bůžková, P., Norby, F. L., Yee, L. M., Heckbert, S. R., Prineas, R. J., Soliman, E. Z., Adabağ, S., Konety, S., et al. (2012) · JAMA Internal Medicine · doi:10.1001/2013.jamainternmed.744 · Cited by 224
Catheter Ablation Versus Medical Therapy for Atrial Fibrillation
Asad, Z. U. A., Yousif, A., Khan, M. S., Al‐Khatib, S. M., & Stavrakis, S. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007414 · Cited by 226
Animal models of arrhythmia: classic electrophysiology to genetically modified large animals
Clauß, S., Bleyer, C., Schüttler, D., Tomsits, P., Renner, S., Klymiuk, N., Wakili, R., Maßberg, S., Wolf, E., & Kääb, S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0179-0 · Cited by 233
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation
Kääb, S., Darbar, D., van Noord, C., Dupuis, J., Pfeufer, A., Newton‐Cheh, C., Schnabel, R. B., Makino, S., Sinner, M. F., Kannankeril, P. J., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn578 · Cited by 220
Self-citation
Atrial Fibrillation and Morbidity and Mortality in a Cohort of Long-term Hemodialysis Patients
Genovesi, S., Vincenti, A., Rossi, E., Pogliani, D., Acquistapace, I., Stella, A., & Valsecchi, M. G. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.10.034 · Cited by 213
Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke
Piccini, J. P., Hammill, B. G., Sinner, M. F., Hernandez, A. F., Walkey, A. J., Benjamin, E. J., Curtis, L. H., & Heckbert, S. R. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht483 · Cited by 215
Self-citation
Comorbidity of atrial fibrillation and heart failure
Ling, L., Kistler, P. M., Kalman, J. M., SCHILLING, R. J., & Hunter, R. J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.191 · Cited by 217
Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure
Kück, K., Merkely, B. P., Zahn, R., Arentz, T., Seidl, K., Schlüter, M., Tilz, R. R., Piorkowski, C., Gellér, L., Kleemann, T., et al. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007731 · Cited by 221
Lone Atrial Fibrillation
Wyse, D. G., Gelder, I. C. V., Ellinor, P. T., Go, A. S., Kalman, J. M., Narayan, S. M., Nattel, S., Schotten, U., & Rienstra, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.023 · Cited by 217
Atrial Fibrillation
Ko, D., Chung, M. K., Evans, P. T., Benjamin, E. J., & Helm, R. H. (2024) · JAMA · doi:10.1001/jama.2024.22451 · Cited by 232
Self-citation
Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure
Hoppe, U. C., Casares, J. M., Eiskjær, H., Hagemann, A., Cleland, J. G. F., Freemantle, N., & Erdmann, E. (2006) · Circulation · doi:10.1161/circulationaha.106.614560 · Cited by 202
Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes
Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.220 · Cited by 199
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension
Manolis, A. J., Rosei, E. A., Coca, A., Cifkova, R., Erdine, S. E., Kjeldsen, S., Lip, G. Y. H., Narkiewicz, K., Parati, G., Redon, J., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f03bf · Cited by 198
“Atrial fibrillation complicates or is frequently associated with other cardiovascular disorders, and the two most important ones are stroke and heart failure (Table 1) [39–42].”
Background
Role of AV Nodal Ablation in Cardiac Resynchronization in Patients With Coexistent Atrial Fibrillation and Heart Failure
Ganesan, A. N., Brooks, A. G., Roberts‐Thomson, K. C., Lau, D. H., Kalman, J. M., & Sanders, P. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.891 · Cited by 197
The State of the Art
Morin, D. P., Bernard, M. L., Madias, C. A., Rogers, P. A., Thihalolipavan, S., & Estes, N. A. M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.08.022 · Cited by 201
Rate control in atrial fibrillation
Gelder, I. C. V., Rienstra, M., Crijns, H. J. G. M., & Olshansky, B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31258-2 · Cited by 212
Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W., Seward, J. B., Iwasaka, T., & Tsang, T. S. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi694 · Cited by 192
“0001 Diabetes mellitus 488 (15) 86 (15) 78 (12) 128 (15) 196 (16) 0.”
Influential
Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: Results from the RAte Control versus Electrical cardioversion (RACE) study
Hagens, V. E., Crijns, H. J. G. M., van Veldhuisen, D. J., van den Berg, M. P., Rienstra, M., Ranchor, A. V., Bosker, H. A., Otto Kamp, B., Tijssen, J. G. P., Veeger, N. J. G. M., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.11.030 · Cited by 189
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
Li, H., Lip, G. Y. H., Feng, Q., Fei, Y., Tse, Y.-K., Wu, M.-Z., Ren, Q.-W., Tse, H., Cheung, B. M. Y., & Yiu, K. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01293-8 · Cited by 197
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis
Nasr, I. A., Bouzamondo, A., Hulot, J., Dubourg, O., Heuzey, J. Y. L., & Lechat, P. P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl484 · Cited by 187
Association of Atrial Fibrosis Quantified Using LGE‐MRI with Atrial Appendage Thrombus and Spontaneous Contrast on Transesophageal Echocardiography in Patients with Atrial Fibrillation
AKOUM, N. W., Fernandez, G., Wilson, B. D., McGann, C. J., Kholmovski, E. G., & MARROUCHE, N. F. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12199 · Cited by 185
Sudden death and associated factors in a historical cohort of chronic haemodialysis patients
Genovesi, S., Valsecchi, M. G., Rossi, E., Pogliani, D., Acquistapace, I., Cristofaro, V. D., Stella, A., & Vincenti, A. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp104 · Cited by 183
Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study , ,
Lutsey, P. L., Alonso, Á., Michos, E. D., Loehr, L. R., Astor, B. C., Coresh, J., & Folsom, A. R. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.085167 · Cited by 184
A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFÉ-II Study)
Shelton, R. J., Clark, A. L., Goode, K. M., Rigby, A. S., Houghton, T., Kaye, G., & Cleland, J. G. F. (2009) · Heart · doi:10.1136/hrt.2008.158931 · Cited by 181
Cardiac sodium channel mutation in atrial fibrillation
Ellinor, P. T., Nam, E. G., Shea, M. A., Milan, D. J., Ruskin, J. N., & MacRae, C. A. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.09.015 · Cited by 180
Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation: A Systematic Review
Al-Khatib, S. M., Allen LaPointe, N. M., Chatterjee, R., Crowley, M. J., Dupre, M. E., Kong, D. F., Lopes, R. D., Povsic, T. J., Raju, S. S., Shah, B., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1467 · Cited by 178
Tissue Doppler-derived index of left ventricular filling pressure, E/E′, predicts survival of patients with non-valvular atrial fibrillation
Okura, H., Takada, Y., Kubo, T., Iwata, K., Mizoguchi, S., Taguchi, H., Toda, I., Yoshikawa, J., & Yoshida, K. (2006) · Heart · doi:10.1136/hrt.2005.082594 · Cited by 178
Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction: A Scientific Statement From the American Heart Association
Gopinathannair, R., Chen, L. Y., Chung, M. K., Cornwell, W. K., Furie, K. L., Lakkireddy, D. R., Marrouche, N. F., Natale, A., Olshansky, B., & Joglar, J. A. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/hae.0000000000000078 · Cited by 187
An Update on the Prognosis of Patients With Atrial Fibrillation
McManus, D. D., Rienstra, M., & Benjamin, E. J. (2012) · Circulation · doi:10.1161/circulationaha.112.129759 · Cited by 178
Self-citation
A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women
Conen, D., Ridker, P. M., Everett, B. M., Tedrow, U. B., Rose, L. M., Cook, N. R., Buring, J. E., & Albert, C. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq146 · Cited by 177
Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem
Zozina, V. I., Covanţev, S., Goroshko, O. A., Красных, Л. М., & Kukes, V. G. (2018) · Current Cardiology Reviews · doi:10.2174/1573403x14666180416115428 · Cited by 177
“The prevalence of the Atrial Fibrillation (AF) and HF are growing worldwide year by year [67].”
Background
Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation
Ellinor, P. T., Low, A. F.-H., Patton, K. K., Shea, M. A., & MacRae, C. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.045 · Cited by 175
Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation
Gasparini, M., Leclercq, C., Lunati, M., Landolina, M., Auricchio, A., Santini, M., Boriani, G., Lamp, B., Proclemer, A., Curnis, A., et al. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.06.003 · Cited by 176
Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC‐NCS (Atherosclerosis Risk in Communities Neurocognitive Study)
Chen, L. Y., Norby, F. L., Gottesman, R. F., Mosley, T. H., Soliman, E. Z., Agarwal, S. K., Loehr, L. R., Folsom, A. R., Coresh, J., & Alonso, Á. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007301 · Cited by 181
“Prevalent heart failure 546 (4) 388 (4) 158 (8)”
Left Atrial Volume Is a Predictor of Atrial Fibrillation Recurrence After Catheter Ablation
Shin, S., Park, M.-Y., Oh, W.-J., Hong, S. J., Pak, H., Song, W.-H., Lim, D., Kim, Y., & Shim, W. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.10.022 · Cited by 169
Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review)
Bizhanov, K. A., Аbzaliyev, K., Baimbetov, A. K., Sarsenbayeva, A., & Lyan, E. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15759 · Cited by 182
“diastolic dysfunction assessed by echocardiography, which gives the highest risk.(47) HF as a result associated with AF.”
Method
P Wave Duration and Risk of Longitudinal Atrial Fibrillation in Persons ≥60 Years Old (from the Framingham Heart Study)
Magnani, J. W., Johnson, V. M., SULLIVAN, L. M., Gorodeski, E. Z., Schnabel, R. B., Lubitz, S. A., Levy, D. A., Ellinor, P. T., & Benjamin, E. J. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.10.075 · Cited by 167
Self-citation
Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality
Magnani, J. W., Norby, F. L., Agarwal, S. K., Soliman, E. Z., Chen, L. Y., Loehr, L. R., & Alonso, Á. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1025 · Cited by 166
Usefulness of Left Atrial Volume Index to Predict Heart Failure Hospitalization and Mortality in Ambulatory Patients With Coronary Heart Disease and Comparison to Left Ventricular Ejection Fraction (from the Heart and Soul Study)
Ristow, B., Ali, S., Whooley, M. A., & Schiller, N. B. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.099 · Cited by 161
Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery
Aragam, K. G., Chaffin, M. D., Levinson, R. T., McDermott, G. C., Choi, S. H., Shoemaker, M. B., Haas, M. E., Weng, L.-C. C., Lindsay, M. E., Smith, J. G., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035774 · Cited by 156
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction
Mogensen, U. M., Jhund, P. S., Abraham, W. T., Desai, A. S., Dickstein, K., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K. B., Zile, M. R., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.027 · Cited by 160
“Although the number of patients and events in this category was relatively small, we believe that it is real and has been reported previously (4,6,26).”
Background
Atrial Fibrillation and Mortality in Heart Failure
Chamberlain, A. M., Redfield, M. M., Alonso, Á., Weston, S. A., & Roger, V. L. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.962688 · Cited by 158
A 12-Year Follow-up Study of Patients With Newly Diagnosed Lone Atrial Fibrillation
Potpara, T., Stankovic, G. R., Beleslin, B., Polovina, M. M., Marinković, J., Ostojić, M., & Lip, G. Y. H. (2011) · CHEST Journal · doi:10.1378/chest.11-0340 · Cited by 157
Impact of Atrial Fibrillation on Exercise Capacity in Heart Failure With Preserved Ejection Fraction
Zakeri, R., Borlaug, B. A., McNulty, S. E., Mohammed, S. F., Lewis, G. D., Semigran, M. J., Deswal, A. M., LeWinter, M. M., Hernandez, A. F., D, E. B. M., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000568 · Cited by 158
“123 Atrial fibrillation (AF) and heart failure (HF) commonly coexist and the presence of each worsens the outcome of the other.(1) The prevalence of AF in HF with preserved left ventricular ejection fraction (HFpEF; LVEF≥50%) is similar to that observed in patients with HF and reduced EF (HFrEF).”
Background
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials
Rahimi, K., Emberson, J., McGale, P., Majoni, W., Merhi, A., Asselbergs, F. W., Krane, V., Macfarlane, P. W., & Executive, P. I. A. O. B. O. T. P. (2011) · BMJ · doi:10.1136/bmj.d1250 · Cited by 159
PULSE‐SMART: Pulse‐Based Arrhythmia Discrimination Using a Novel Smartphone Application
McMANUS, D. D., CHONG, J. W., SONI, A., SACZYNSKI, J. S., ESA, N., NAPOLITANO, C., DARLING, C. E., BOYER, E., ROSEN, R. K., FLOYD, K. C., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12842 · Cited by 156
Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients
Abe, Y., Akamatsu, K., Ito, K., Matsumura, Y., Shimeno, K., Naruko, T., Takahashi, Y., Shibata, T., & Yoshiyama, M. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-1334 · Cited by 156
“Diabetes mellitus 68 (28) 4 (12) 1 (8) 1 (9) 0.”
Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting?
Ngaage, D. L., Schaff, H. V., Mullany, C. J., Sundt, T. M., Dearani, J. A., Barnes, S. A., Daly, R. C., & Orszulak, T. A. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.09.021 · Cited by 155
Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study
Hippisley-Cox, J., Coupland, C., & Brindle, P. (2013) · British medical journal · doi:10.1136/bmj.f2573 · Cited by 164
Clinical and Prognostic Effects of Atrial Fibrillation in Heart Failure Patients with Reduced and Preserved Left Ventricular Ejection Fraction
Linssen, G. C. M., Rienstra, M., Jaarsma, T., Voors, A. A., Gelder, I. C. V., Hillege, H. L., & van Veldhuisen, D. J. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr066 · Cited by 153
Features of Atrial Fibrillation in Wild-Type Transthyretin Cardiac Amyloidosis: A Systematic Review and Clinical Experience
Mints, Y. Y., Doros, G. D., Berk, J. L., Connors, L. H., & Ruberg, F. L. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12308 · Cited by 152
High left atrial pressures are associated with advanced electroanatomical remodeling of left atrium and independent predictors for clinical recurrence of atrial fibrillation after catheter ablation
Park, J., Joung, B., Uhm, J., Shim, C. Y., Hwang, C., Lee, M., & Pak, H. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.009 · Cited by 151
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
Wong, J. A., Conen, D., Gelder, I. C. V., McIntyre, W. F., Crijns, H. J. G. M., Wang, J., Gold, M. R., Hohnloser, S. H., Lau, C., Capucci, A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.519 · Cited by 152
“Heart failure (HF) develops in up to 40% of patients with AF (13,14) and is the cause of 15% to 30% of all deaths in this patient population (10,15,16).”
Background
Outcomes of Medicare Beneficiaries Undergoing Catheter Ablation for Atrial Fibrillation
Piccini, J. P., Sinner, M. F., Greiner, M. A., Hammill, B. G., Fontes, J. D., Daubert, J. P., Ellinor, P. T., Hernandez, A. F., Walkey, A. J., Heckbert, S. R., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.109330 · Cited by 150
Self-citation
Atrial Fibrillation in Congestive Heart Failure
Lubitz, S. A., Benjamin, E. J., & Ellinor, P. T. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.11.001 · Cited by 151
“The temporal relations of AF and CHF were examined in a study of 1470 patients with new onset AF or CHF from the Framingham Heart Study (30).”
BackgroundSelf-citation
P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey
Magnani, J. W., Gorodeski, E. Z., Johnson, V. M., SULLIVAN, L. M., Hamburg, N. M., Benjamin, E. J., & Ellinor, P. T. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.09.020 · Cited by 148
Self-citation
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design
Packer, D. L., Mark, D. B., Robb, R. A., Monahan, K. H., Bahnson, T. D., Moretz, K., Poole, J. E., Mascette, A. M., Rosenberg, Y., Jeffries, N. O., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.02.015 · Cited by 151
Outcomes registry for better informed treatment of atrial fibrillation: Rationale and design of ORBIT-AF
Piccini, J. P., Fraulo, E. S., Ansell, J., Fonarow, G. C., Gersh, B. J., Go, A. S., Hylek, E. M., Kowey, P. R., Mahaffey, K. W., Thomas, L. E., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.07.001 · Cited by 147
Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study
Saliba, W., Gronich, N., Barnett‐Griness, O., & Rennert, G. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.02.029 · Cited by 146
Electroimmunology and cardiac arrhythmia
Grune, J., Yamazoe, M., & Nahrendorf, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00520-9 · Cited by 161
Acacetin, a Natural Flavone, Selectively Inhibits Human Atrial Repolarization Potassium Currents and Prevents Atrial Fibrillation in Dogs
Li, G., Wang, H., Qin, G.-W., Jin, M., Tang, Q., Sun, H., Du, X., Deng, X., Zhang, X., Chen, J., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.769554 · Cited by 142
Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea
Lee, S. S., Kong, K. A., Kim, D., Lim, Y.-M., Yang, P., Yi, J., Kim, M., Kwon, K., Pyun, W. B., Joung, B., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx316 · Cited by 143
Multifractal Desynchronization of the Cardiac Excitable Cell Network During Atrial Fibrillation. I. Multifractal Analysis of Clinical Data
Attuel, G., Gerasimova-Chechkina, E., Argoul, F., Yahia, H. M., & Arnéodo, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2017.01139 · Cited by 142
“This condition alone requires treatment of the atrial electrophysiological substrate, all themore so as AF often coexists with and predisposes to heart failure, with increased morbidity andmortality (Middlekauff et al., 1991; Stevenson and Stevenson, 1999; Wang et al., 2003).”
Background
Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction
Li, S., Sartipy, U., Lund, L. H., Dahlström, U., Adiels, M., Petzold, M., & Fu, M. L. X. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002285 · Cited by 141
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation
Pandey, A., Kim, S., Moore, C., Thomas, L. E., Gersh, B. J., Allen, L. A., Kowey, P. R., Mahaffey, K. W., Hylek, E. M., Peterson, E. D., et al. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.09.016 · Cited by 141
Upper Normal Blood Pressures Predict Incident Atrial Fibrillation in Healthy Middle-Aged Men
Grundvold, I., Skretteberg, P. T., Liestøl, K., Erikssen, G., Kjeldsen, S. E., Arnesen, H., Erikssen, J. E., & Bodegård, J. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.179713 · Cited by 140
Epidemiology of atrial fibrillation: A current perspective
Chen, L. Y., & Shen, W.-K. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.12.018 · Cited by 140
Minimum vs. maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study
Fatema, K., Barnes, M. E., Bailey, K. R., Abhayaratna, W. P., Cha, S., Seward, J. B., & Tsang, T. S. M. (2008) · European Journal of Echocardiography · doi:10.1093/ejechocard/jen235 · Cited by 139
Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection Fraction
McManus, D. D., Hsu, G., Sung, S. H., Saczynski, J. S., Smith, D. H., Magid, D. J., Gurwitz, J. H., Goldberg, R. J., & Go, A. S. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.005694 · Cited by 139
“The epidemiologic similarities between AF and HF, as well as their frequent concurrence, are explained, at least in part, by shared underlying risk factors, including hypertension, diabetes mellitus, chronic kidney disease, ischemic heart disease, and valvular heart disease.25 As expected, we found that patients with…”
BackgroundResultInfluential
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
Chiang, C., Wu, T.-J., Ueng, K.-C., Chao, T., Chang, K., Wang, C.-C., Lin, Y., Yin, W., Kuo, J., Lin, W., et al. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.10.005 · Cited by 138
Current Perceptions of the Epidemiology of Atrial Fibrillation
Kannel, W. B., & Benjamin, E. J. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.09.015 · Cited by 138
“Framingham Study data indicate that AF and heart failure often coexist and that each may have an adverse impact on the other.(34) The decreased survival rate associated with AF occurs across a wide age range and is partially attributable to the vulnerability of patients who have AF to heart failure.”
Self-citation
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey
Rivero‐Ayerza, M., Reimer, W. J. M. S. O., Lenzen, M. J., Theuns, D. A. M. J., Jordaens, L. J. L. M., Michel Komajda, N., Folláth, F., Swedberg, K. B., & Cleland, J. G. F. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn217 · Cited by 134
“Clinical variables, treatment, length of stay in the coronary care unit/intensive care unit (CCU/ICU), length of hospitalization, hospital survival, and cause of death were analysed according to the type of AF.”
Influential
Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction
Hanna, I. R., Heeke, B., Bush, H., Brosius, L., King-Hageman, D., Dudley, S. C., Beshai, J. F., & Langberg, J. J. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.05.010 · Cited by 132
Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort
Miyasaka, Y., Barnes, M. E., Petersen, R. C., Cha, S. S., Bailey, K. R., Gersh, B. J., Casaclang-Verzosa, G., Abhayaratna, W. P., Seward, J. B., Iwasaka, T., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm012 · Cited by 133
Serum potassium levels and the risk of atrial fibrillation
Krijthe, B. P., Heeringa, J., Kors, J. A., Albert Hofman, D., Franco, O. H., Witteman, J. C. M., & Stricker, B. H. C. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.048 · Cited by 134
“Atrial fibrillation is associated with a 3 to 5 times higher risk of stroke [1], and with a higher risk of heart failure, cardiac mortality, and total mortality [2,3].”
Background
Genetic Obesity and the Risk of Atrial Fibrillation
Chatterjee, N. A., Giulianini, F., Geelhoed, B., Lunetta, K. L., Misialek, J. R., Niemeijer, M. N., Rienstra, M., Rose, L. M., Smith, A. V., Arking, D. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.024921 · Cited by 136
Self-citation
Risk Assessment for Incident Heart Failure in Individuals With Atrial Fibrillation
Schnabel, R. B., Rienstra, M., SULLIVAN, L. M., Sun, F. X., Moser, C., Levy, D. A., Pencina, M. J., Fontes, J. D., Magnani, J. W., McManus, D. D., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft041 · Cited by 133
Self-citation
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure
Turagam, M. K., Garg, J., Whang, W., Sartori, S., Koruth, J. S., Miller, M. A., Langan, N., Sofi, A. A., Gomes, A., Choudry, S., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0992 · Cited by 133
Atrial Fibrillation and Aortic Stenosis
Stortecky, S., Buellesfeld, L., Wenaweser, P., Heg, D., Pilgrim, T., Khattab, A. A., Gloekler, S., Huber, C. H., Nietlispach, F., Meier, B., et al. (2013) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.000124 · Cited by 134
“Previous CABG, n (%) 72 (19) 56 (22) 16 (12) 0.”
Atrial Fibrillation and Cognitive Decline–The Role of Subclinical Cerebral Infarcts
Chen, L. Y., Norby, F. L., Gottesman, R. F., Huxley, R., Agarwal, S. K., Loehr, L. R., Mosley, T. H., & Alonso, Á. (2014) · Stroke · doi:10.1161/strokeaha.114.005243 · Cited by 134
Development of heart failure in recent hypertension trials
Tocci, G., Sciarretta, S., & Volpe, M. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282fe1d3d · Cited by 133
Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar
Maret, E., Tödt, T., Brudin, L. H., Nylander, E., Swahn, E., Ohlsson, J. L., & Engvall, J. E. (2009) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-7-53 · Cited by 128
“Unless compensated for by hyperkinetic wall motion in remote areas, the physiological effect of a WMA is a reduction in the left ventricular ejection fraction (LVEF) which is closely related to prognosis in chronic coronary artery disease [7-11].”
Urgent Management of Rapid Heart Rate in Patients With Atrial Fibrillation/Flutter and Left Ventricular Dysfunction
Nagai, R., Kinugawa, K., Inoue, H., Atarashi, H., Seino, Y., Yamashita, T., Shimizu, W., Aiba, T., Kitakaze, M., Sakamoto, A., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1618 · Cited by 128
Monogenic and Polygenic Contributions to Atrial Fibrillation Risk
Choi, S. H., Jurgens, S. J., Weng, L.-C. C., Pirruccello, J. P., Roselli, C., Chaffin, M. D., Lee, C. J., Hall, A. W., Khera, A. V., Lunetta, K. L., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315686 · Cited by 129
Adverse prognosis of incidentally detected ambulatory atrial fibrillation
Martínez, C., Katholing, A., & Freedman, S. B. (2014) · Thrombosis and Haemostasis · doi:10.1160/th4-04-0383 · Cited by 130
“Atrial fibrillation (AF) is increasing in prevalence (1) due in part to population ageing, and is associated with a significant but variable increase in risk of stroke (2) (usually large and severe) (3, 4), death (5) and heart failure(6).”
Presence of Atrial Fibrillation Is Independently Associated With Adverse Outcomes in Patients Hospitalized With Heart Failure
Mountantonakis, S., Grau‐Sepulveda, M. V., Bhatt, D. L., Hernandez, A. F., Peterson, E. D., & Fonarow, G. C. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.965681 · Cited by 127
Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry
SCHMIDT, M., DORWARTH, U., ANDRESEN, D., BRACHMANN, J., KUCK, K., KUNISS, M., LEWALTER, T., SPITZER, S., WILLEMS, S., SENGES, J., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12267 · Cited by 126
A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFÉ-II Study)
Cuoco, F. A. (2010) · Yearbook of Cardiology · doi:10.1016/s0145-4145(10)79886-5 · Cited by 124
Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality
Sanchis, K., Cariou, E., Colombat, M., Ribes, D., Huart, A., Cintas, P., Fournier, P., Rollin, A., Carrié, D., Galinier, M., et al. (2019) · Amyloid · doi:10.1080/13506129.2019.1620724 · Cited by 125
“Although the role of AF as a risk factor for mortality has been clearly demonstrated over the last decades [6,7], particularly in heart failure [8], its impact in patients with CA is controversial.”
Background
Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery?
Ngaage, D. L., Schaff, H. V., Barnes, S. A., Sundt, T. M., Mullany, C. J., Dearani, J. A., Daly, R. C., & Orszulak, T. A. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.04.004 · Cited by 124
Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction
Verma, A., Kalman, J. M., & Callans, D. J. (2017) · Circulation · doi:10.1161/circulationaha.116.026054 · Cited by 124
Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation
Chopard, R., Teíger, E., Meneveau, N. F., Chocron, S., Gilard, M., Laskar, M., Eltchaninoff, H., Iung, B., Leprince, P. N., Chevreul, K., et al. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.06.010 · Cited by 124
“Moreover, the loss of atrioventricular synchrony, leading to impaired ventricular filling, reduced cardiac output, and increased afterload, are hemodynamic factors known to adversely affect clinical outcomes in heart failure patients (28).”
Background
Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation
Khadjooi, K., Foley, P. W. X., Chalil, S., Anthony, J., Smith, R. E. A., Frenneaux, M. P., & Leyva, F. (2008) · Heart · doi:10.1136/hrt.2007.129429 · Cited by 117
Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators
Santini, M., Gasparini, M., Landolina, M., Lunati, M., Proclemer, A., Padeletti, L., Catanzariti, D., Molon, G., Botto, G. L., La Rocca, L., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.08.624 · Cited by 121
Management of Atrial Fibrillation in Patients 75 Years and Older
Volgman, A. S., Nair, G. G., Lyubarova, R., Merchant, F. M., Mason, P. K., Curtis, A. B., WENGER, N. K., Aggarwal, N. T., Kirkpatrick, J. N., & Benjamin, E. J. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.10.037 · Cited by 124
Self-citation
Non-cardiac comorbidities in chronic heart failure
Lang, C. C., & MANCINI, D. M. (2006) · Heart · doi:10.1136/hrt.2005.068296 · Cited by 124
“Previous data on the presence and effect of comorbidities on CHF were derived from clinical trials and geographically limited studies of relatively small numbers of patients such as the Framingham cohort.”
Method
Atrial fibrillation and heart failure: natural history and pharmacological treatment
Savelieva, I., & JOHNCAMM, A. (2004) · EP Europace · doi:10.1016/j.eupc.2004.07.003 · Cited by 120
Coenzyme Q10: Clinical Applications in Cardiovascular Diseases
Martelli, A., Testai, L., Colletti, A., & Cicero, A. F. G. (2020) · Antioxidants · doi:10.3390/antiox9040341 · Cited by 121

Authors: Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J.
Affiliations: Boston University (US)
ORCID: Wang, Thomas J.
Larson, Martin G.
Levy, Daniel
Vasan, Ramachandran S.
Wolf, Philip A.
D’Agostino, Ralph B.
Murabito, Joanne M.
Benjamin, Emelia J.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2003-06-17
Volume: 107
Issue: 23
Pages: 2920-2925
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000072767.89944.6e
OpenAlex: W1998083759
Cited by: 1,970
References: 28
Citations by year: 2026: 49 · 2025: 65 · 2024: 114 · 2023: 93 · 2022: 117 · 2021: 137 · 2020: 109 · 2019: 103 · 2018: 120 · 2017: 107 · 2016: 111 · 2015: 115 · 2014: 112 · 2013: 101 · 2012: 84
FWCI: 27.01
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc25195-41-0-1)
National Heart, Lung, and Blood Institute (K24-HL-04334-01A1, N01‐HC25195, K24HL004334)
National Institute of Neurological Disorders and Stroke (5-RO1-NS-17950, R01NS017950)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: atrial fibrillation, congestive heart failure, mortality, comorbidities, prognosis, Framingham Heart Study
MeSH terms: Aged, Atrial Fibrillation, Female, Follow-Up Studies, Heart Failure, Humans, Male, Massachusetts, Middle Aged, Prognosis, Risk Factors, Cohort Studies, Comorbidity, Incidence, Multivariate Analysis, Proportional Hazards Models, Survival Analysis, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks